Table 1.

Drugs that have been studied in relief of COVID-19 clinical presentation.

Drug	Adult Dosage	Pediatric Dosage	Route of Administration
Chloroquine phosphate	500 mg (300 mg for chloroquine base) twice daily25	Not recommended	Oral
Hydroxychloroquine	200 mg twice daily26	Not recommended	Oral
Lopinavir/Ritonavir	400mg/100 mg (2 capsules each time) twice daily26	Lopinavir:BW1 (kg): •7–15 kg: 12 mg/3 mg/kg/time, twice daily for 1–2 weeks •15–40: 10 mg/2.5 mg/kg/time, twice daily for 1–2 weeks •40: 400 mg/100 mg/time, twice daily for 1–2 weeks27	Oral
Ribavirin	500 mg twice dailyin combination with IFN-α or lopinavir/ritonavir25	10 mg/kg every time (maximum 500 mg every time), 2–3 times daily 27	IV infusion
IFN-α2	5 million U twice daily25	200,000–400,000 IU/kg or 2–4 μg/kg in 2 mL sterile water, twice daily for 5–7 days 27	Vapor inhalation (nebulization)
Umifenovir	200 mgthree times daily26	Not recommended	Oral
Remdesivir	200 mg loading dose on the first day Followed by 100 mg once daily 28	•BW1 of 3.5-40 kg: 5 mg/kg loading dose on the first day followed by 2.5 mg/kg once daily from the second day •BW1 of ≥ 40 kg: similar to the adult dosage29.	IV infusion
Tocilizumab	8 mg/kg every 4 weeks 30	Not recommended	IV infusion (during 60 min)
Teicoplanin	400 mg daily31	Not recommended	IV infusion
Favipiravir	1600-2400 mg loading dose on the first day Followed by 200-600 mg twice daily 26	Not recommended	Oral

¹Body weight

²Interferon alpha